On Wednesday, some news channels carried reactions of the relatives of patient administered with Remdesivir at the hospital, showing that old expiry date was covered by a new sticker.
Russia's Sputnik V vaccine is currently being manufactured in India by Dr Reddy's Laboratories.
The decision by the Drugs Controller General of India comes in the backdrop of Pfizer and Cipla putting forth similar demands during negotiations to supply imported vaccines to India.
Clinical trial results have shown that this molecule helps in faster recovery of hospitalized patients and reduces supplemental oxygen dependence.
The Hyderabad-based Bharat Biotech was given permission for sale and distribution of Covaxin with shelf life of six months when stored at two to eight degrees Celsius.
In a letter to the Serum Institute of India, Drugs Controller General of India V G Somani said the SII is permitted to apply the shelf life of nine months to unlabelled vials available on hand.
Expert panel reviews emergency use application for Sputnik V vaccine; seeks immunogenicity, safety data
Dr Reddy's Laboratories on February 19 said it had approached drugs regulator DCGI for emergency use authorisation (EUA) for the Russian vaccine.
The trial has reviewed by an independent data safety monitoring board and reports were submitted to the Central Drugs Standard Control Organisation regularly for the update on safety outcome.
COVID-19 vaccines of Serum Institue of India and Bharat Biotech have been granted permission for restricted use in an emergency situation.
The SEC made its recommendations in respect of the accelerated approval process request of the SII, Bharat Biotech International Ltd as well as about phase-III trials of Cadila Healthcare Ltd.
The Pune-based Serum Institute of India, the world's largest vaccine manufacturer, has tied up with AstraZeneca to manufacture 'Covishield'.
DCGI seeking more data for granting emergency use authorisation won't impact timeline for vaccine roll-out: Government
The applications filed before the DCGI are being examined by the subject expert committee on COVID-19 of CDSCO for emergency use authorisation.
A top health ministry official said a series of meetings could be held before the committee submits its recommendations.
The British regulator said the jab, which claims to offer up to 95 per cent protection against COVID-19, is safe for roll-out.
The development comes less than a month after the Russian government announced its partnership with Dr Reddy’s Laboratories for mass vaccinations by the year-end.